Search

Your search keyword '"Matias Greve Lindholm"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Matias Greve Lindholm" Remove constraint Author: "Matias Greve Lindholm"
52 results on '"Matias Greve Lindholm"'

Search Results

1. The CHIP-clinic as the catalyst of preventive medicine

2. DANSPOT: A Multicenter Stepped‐Wedge Cluster‐Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design

3. Thoracentesis to alleviate pleural effusion in acute heart failure: study protocol for the multicentre, open-label, randomised controlled TAP-IT trial

4. Myocardial Work in Patients Hospitalized With COVID‐19: Relation to Biomarkers, COVID‐19 Severity, and All‐Cause Mortality

5. Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study

6. Echocardiographic abnormalities and predictors of mortality in hospitalized COVID‐19 patients: the ECHOVID‐19 study

7. Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMI

8. Is the high intensity symptoms experienced by patients admitted with chronic obstructive pulmonary disease documented by health professionals? - a prospective survey with comparison of patient reported outcomes and medical records

10. Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events:the ECHOVID-19 study

11. Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm

12. Lung ultrasound findings following COVID-19 hospitalization: A prospective longitudinal cohort study

13. Lung Ultrasound Findings Associated With COVID-19 ARDS, ICU Admission, and All-Cause Mortality

14. Repolarization and ventricular arrhythmia during targeted temperature management post cardiac arrest

15. Recovery of cardiac function following COVID-19 - ECHOVID-19: a prospective longitudinal cohort study

16. Myocardial Impairment and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19

17. Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction

18. Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients:the ECHOVID-19 study

19. Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction

20. Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMI

21. Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality

22. P5012Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study

23. Jeopardized Myocardium and Survival in Patients Presenting to the Catheterization Laboratory With ST-Elevation Myocardial Infarction and Shock

24. Rationale and design of DanGer shock:Danish-German cardiogenic shock trial

25. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction

26. Cardiac output, heart rate and stroke volume during targeted temperature management after out-of-hospital cardiac arrest: Association with mortality and cause of death

27. Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients With Cardiogenic Shock - Results from the Cardshock Study

28. Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study

29. Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients with Suspected St-Elevation Myocardial Infarction Complicated by Cardiogenic Shock

30. Are symptoms experienced by patients admitted with COPD documented by health professionals? - A survey

31. Is the high intensity symptoms experienced by patients admitted with chronic obstructive pulmonary disease documented by health professionals? - a prospective survey with comparison of patient reported outcomes and medical records

32. The Glucagon-Like Peptide-1 Analog Exenatide Increases Blood Glucose Clearance, Lactate Clearance, and Heart Rate in Comatose Patients After Out-of-Hospital Cardiac Arrest

33. Predictive value of the baseline electrocardiogram ST-segment pattern in cardiogenic shock: Results from the CardShock Study

34. P4640Biomarkers of endothelial damage are associated with cardiogenic shock in patients admitted with suspected ST-elevation myocardial infarction

35. 4998Current use and impact on 30-day mortality of pulmonary artery catheter in cardiogenic shock patients: results from the CardShock Study

36. Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality

37. Adrenomedullin : a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock

38. Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMI

39. Use of noninvasive and invasive mechanical ventilation in cardiogenic shock. A prospective multicenter study

40. Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest:A Randomized Controlled Trial

41. Pre-hospital diagnosis and transfer of patients with acute myocardial infarction—a decade long experience from one of Europe's largest STEMI networks

42. Simple Risk Stratification at Admission to Identify Patients With Reduced Mortality From Primary Angioplasty

43. Cardiogenic shock complicating acute myocardial infarction Prognostic impact of early and late shock development

44. ASSOCIATION BETWEEN QRS DURATION ON PREHOSPITAL ELECTROCARDIOGRAM AND EARLY OUTCOME IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

45. Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis

46. [Percutaneous assist device during acute heart failure]

47. [A new percutan assist device for treatment of fulminant myocarditis]

48. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock

49. Diabetes mellitus and cardiogenic shock in acute myocardial infarction

50. Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience

Catalog

Books, media, physical & digital resources